The glucagon-like peptide-1 (GLP-1) receptor agonist drug class—which includes diabetes drugs Wegovy and Ozempic—is proving effective at managing obesity, leading to surging demand.

Health plan sponsors need to understand the mechanics of the Medicare Prescription Payment Plan and prepare for the program’s operational complexity.

When seeking ways to keep expenses under control, plan sponsors may overlook the value of claims auditing.....

As drug costs continue to rise, states need to engage in strategies that include policy and nonpolicy options to manage prescription spending in Medicaid.

A review of best practices for plan sponsors in evaluating clinical programs offered by pharmacy benefit managers.

One of the most important ways plan sponsors can lower healthcare costs without significantly changing their benefits is to look for opportunities to improve their pharmacy benefit manager (PBM) contract.

Auditing the administration of the pharmaceutical manufacturer rebate program, including dollars paid, is a proven strategy for improving plan sponsor profitability, prescription drug affordability, and the management of pharmacy benefit manager contracts.

Employers and other plan sponsors have the option of carving in or carving out their pharmacy benefit program from medical benefits. Which strategy is right for you?